Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

4 results found

Interview |

08 August 2011

Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries

Tags HIV/AIDSIntellectual property and trade HIV/AIDS raltegravirantiretroviral medicines compulsory licencepatent poolTRIPS Brazil

Feature story |

01 July 2011

Major milestones in patents and access to medicines

Tags compulsory licenceDoha Declarationpatent poolTRIPS Novartis Drop the Case Campaign South AfricaIndiaThailand

Thumbnail

Video |

29 March 2010

Khayelitsha: Patient & Doctor Testimonies on the desperate need for improved access to AIDS meds

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines patent pool South Africa

Feature story |

23 October 2009

AIDS Emergency is Far from Over

AIDS Emergency is Far from Over

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines patent pool UNITAID South Africa